Key points are not available for this paper at this time.
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed
Lin et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: